Company Filing History:
6 out of 499 
1 out of 614 
Years Active: 1984-1993
Title: Kohei Umezu: Innovator in Pharmaceutical Chemistry
Introduction
Kohei Umezu is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating hyperlipemia and atherosclerosis. With a total of 7 patents to his name, Umezu's work has had a considerable impact on medical science.
Latest Patents
Umezu's latest innovations include a novel 1-phenylalkyl-3-phenylurea derivative. This compound is designed to reduce cholesterol levels in the blood through ACAT inhibition, making it useful for treating conditions such as hyperlipemia and atherosclerosis. Another significant patent is a pyrrolealdehyde derivative, which is effective in lowering triglyceride and cholesterol levels in serum. These compounds are valuable as active ingredients in pharmaceutical compositions aimed at addressing cardiovascular health issues.
Career Highlights
Throughout his career, Umezu has worked with notable companies, including Mitsubishi Kasei Corporation and Mitsubishi Chemical Industries Limited. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.
Collaborations
Umezu has collaborated with esteemed colleagues such as Shinya Inoue and Kazuo Suzuki. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Kohei Umezu's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key figure in the field. His work continues to influence the development of treatments for critical health issues.